PHK
TXG icon

Point72 Hong Kong’s 10x Genomics TXG Stock Holding History

Point72 Hong Kong’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,045
Closed -$2.63M – 724
2024
Q1 		$2.63M Buy
+70,045
New +$3.08M 0.13% 172
2022
Q2 		– Sell
-5,863
Closed -$446K – 2419
2022
Q1 		$446K Buy
5,863
+3,614
+161% +$316K 0.02% 738
2021
Q4 		$335K Buy
2,249
+911
+68% +$140K 0.01% 881
2021
Q3 		$195K Sell
1,338
-7,750
-85% -$1.33M 0.01% 1175
2021
Q2 		$1.78M Buy
+9,088
New +$1.64M 0.06% 471
2021
Q1 		– Sell
-6,232
Closed -$882K – 2222
2020
Q4 		$882K Buy
+6,232
New +$904K 0.04% 527
2020
Q3 		– Sell
-318
Closed -$28K – 1547
2020
Q2 		$28K Buy
+318
New +$24.8K ﹤0.01% 840
2019
Q4 		– Sell
-6,029
Closed -$304K – 1466
2019
Q3 		$304K Buy
+6,029
New +$334K 0.09% 184

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Point72 Hong Kong's TXG Position: Q2 2024 in Review

Point72 Hong Kong sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 70,045 shares — an estimated $2.63M sold.

Point72 Hong Kong first reported a position in TXG in Q3 2019 and held it in 8 quarters. The position peaked at $2.63M in Q1 2024. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Point72 Hong Kong reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 70,045 10x Genomics shares in Q2 2024, an estimated $2.63M.
  • Point72 Hong Kong first reported a position in 10x Genomics in Q3 2019 and held it in 8 quarters.
  • Point72 Hong Kong's 10x Genomics position peaked at $2.63M in Q1 2024.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.